RTN4 and experimental autoimmune encephalomyelitis: For example, intravenous bolus injections of a blocking antibody binding the delta 20 domain of Nogo-A [12], similarly to 11C7 mAb, dramatically reduced the severity of experimental autoimmune encephalomyelitis (EAE) [10].